<生产厂家价格>

(R)-1-Boc-3-羟基吡咯烷

(R)-1-Boc-3-羟基吡咯烷用途

(R) -(-)-Boc-3-吡咯烷醇是一种生物化学试剂,可作为生物材料或有机化合物用于生命科学相关研究。

(R)-1-Boc-3-羟基吡咯烷名称

[ CAS 号 ]:
109431-87-0

[ 中文名 ]:
(R)-1-Boc-3-羟基吡咯烷

[ 英文名 ]:
(R)-(-)-N-Boc-3-pyrrolidinol

[中文别名 ]:

[英文别名 ]:

(S)-1-N-Boc-3-Hydroxypyrrolidine
(R)-1-tert-Butoxycarbonyl-(−)-3-pyrrolidinol
(S)-(+)-N-BOC-3-pyrrolidinol
R)-(-)-N-Boc-3-pyrrolidinol
(R)-1-(tert-Butoxycarbonyl)-3-hydroxypyrrolidine
N-t-BOC-(R)-3-Hydroxypyrrolidine
(S)-1-(tert-Butoxycarbonyl)-3-pyrrolidinol
(R)-N-(tert-Butoxycarbonyl)-3-hydroxypyrrolidine
(R)-(-)-N-BOC-3-pyrrolidinol
(R)-tert-Butyl 3-hydroxypyrrolidine-1-carboxylate

(R)-1-Boc-3-羟基吡咯烷生物活性

[ 描述 ]:

(R) -(-)-Boc-3-吡咯烷醇是一种生物化学试剂,可作为生物材料或有机化合物用于生命科学相关研究。

[ 相关类别 ]:

研究领域 >> 其他

(R)-1-Boc-3-羟基吡咯烷物理化学性质

[ 密度 ]:
1.1±0.1 g/cm3

[ 沸点 ]:
273.3±33.0 °C at 760 mmHg

[ 熔点 ]:
62-65 °C(lit.)

[ 分子式 ]:
C₉H₁₇NO₃

[ 分子量 ]:
187.24

[ 闪点 ]:
119.1±25.4 °C

[ 精确质量 ]:
187.120850

[ PSA ]:
49.77000

[ LogP ]:
-0.08

[ 外观性状 ]:
白色至灰白色粉末

[ 蒸汽压 ]:
0.0±1.3 mmHg at 25°C

[ 折射率 ]:
1.502

[ 储存条件 ]:
2~8°C

[ 水溶解性 ]:
可溶于：甲醇

(R)-1-Boc-3-羟基吡咯烷MSDS

详细MSDS(安全技术说明书)

(R)-1-Boc-3-羟基吡咯烷安全信息

[ 符号 ]:

GHS07, GHS09

[ 信号词 ]:
Warning

[ 危害声明 ]:
H315-H319-H335-H400

[ 警示性声明 ]:
P261-P273-P305 + P351 + P338

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Gloves

[ 危害码 (欧洲) ]:
Xi:Irritant

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
S26-S36

[ 危险品运输编码 ]:
UN 3077 9 / PGIII

[ WGK德国 ]:
3

[ 海关编码 ]:
2933990090

(R)-1-Boc-3-羟基吡咯烷海关

[ 海关编码 ]: 2933990090

[ 中文概述 ]:
2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

(R)-1-Boc-3-羟基吡咯烷文献

Design, synthesis and biological activity of amidinobicyclic compounds (derivatives of DX-9065a) as factor Xa inhibitors: SAR study of S1 and aryl binding sites.

Bioorg. Med. Chem. 12 , 2099-2114, (2004)

Since factor Xa (fXa) plays a pivotal role in the blood coagulation cascade, inhibition of fXa is thought to be an effective treatment for a variety of thrombotic events. (2S)-2-[4-[[(3S)-1-Acetimidoy...

Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor.

Bioorg. Med. Chem. Lett. 10 , 1063, (2000)

The preparation of novel pyridyl ethers as ligands for the nicotinic acetylcholine receptor (nAChR) is described. Variations of the ring size of the azacycle and substitution on the pyridine had drama...

更多文献